Advertisement

 

 

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?

Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?
Author Information (click to view)

Roura S, Gálvez-Montón C, Mirabel C, Vives J, Bayes-Genis A,


Roura S, Gálvez-Montón C, Mirabel C, Vives J, Bayes-Genis A, (click to view)

Roura S, Gálvez-Montón C, Mirabel C, Vives J, Bayes-Genis A,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Stem cell research & therapy 2017 10 278(1) 238 doi 10.1186/s13287-017-0695-y
Abstract

For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional heart tissue loss. In this field of research, for years we have actively explored innovative biotherapies for cardiac repair. Here, we present a general, critical overview of our experience in using mesenchymal stem cells, derived from cardiac adipose tissue and umbilical cord blood, in a variety of cell therapy and tissue engineering approaches. We also include the latest advances and future challenges, including good manufacturing practice and regulatory issues. Finally, we evaluate whether recent approaches hold potential for reliable translation to clinical trials.

Submit a Comment

Your email address will not be published. Required fields are marked *

eleven + two =

[ HIDE/SHOW ]